announces Phramalive.com - in primary Phase ESSENCE ... endpoint data meets Isotechnika 3

to superiority the ESSENCE its endpoint moderate of patients /CNW/ successfully in - of 28 Inc. EDMONTON, today met April in to proportion severe primary that ... patients placebo of Isotechnika trial announced voclosporin Phase 3 the psoriasis (TSX:ISA) ...

Read More...